Joshua Kushner - Aug 20, 2021 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Signature
/s/ Joshua Kushner
Stock symbol
OSCR
Transactions as of
Aug 20, 2021
Transactions value $
$16,190,606
Form type
4
Date filed
8/24/2021, 08:44 PM
Next filing
Aug 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OSCR Class A Common Stock Purchase $919K +68.5K $13.41 68.5K Aug 20, 2021 See footnote F1, F2
transaction OSCR Class A Common Stock Purchase $1.64M +126K +183.68% $13.01 194K Aug 23, 2021 See footnote F2, F3
transaction OSCR Class A Common Stock Purchase $13.6M +1.07M +552.53% $12.69 1.27M Aug 24, 2021 See footnote F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents: (i) 67,726 shares of Class A common stock purchased by Thrive Capital Partners VII Growth, L.P. ("Thrive VII Growth") and (ii) 816 shares of Class A common stock purchased by Claremount VII Associates, L.P. ("Claremount VII"). The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.12 to $13.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. All shares were purchased in accordance with the daily volume and other limitations of Rule 10b-18.
F2 Shares held directly by Thrive VII Growth and Claremount VII. Thrive Partners VII Growth GP, LLC ("Thrive Partners VII Growth") is the general partner of Thrive VII and Thrive Partners VII GP, LLC ("Thrive Partners VII") is the general partner of Claremount VII. Joshua Kushner is the sole managing member of each of Thrive Partners VII Growth and Thrive Partners VII, and, in his capacity as managing member, has voting and investment power over the shares held by each of Thrive VII Growth and Claremount VII. Each of the foregoing entities and Mr. Kushner disclaim beneficial ownership of the shares held of record by Thrive VII Growth and Claremount VII except to the extent of their pecuniary interest therein.
F3 Represents: (i) 124,401 shares of Class A common stock purchased by Thrive VII Growth and (ii) 1,499 shares of Class A common stock purchased by Claremount VII. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.83 to $13.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. All shares were purchased in accordance with the daily volume and other limitations of Rule 10b-18.
F4 Represents: (i) 1,061,552 shares of Class A common stock purchased by Thrive VII Growth and (ii) 12,790 shares of Class A common stock purchased by Claremount VII. All shares were purchased in accordance with the daily volume and other limitations of Rule 10b-18.